Reata Pharmaceuticals Cash from Investing (TTM)

Reata Pharmaceuticals Inc (RETA)

31.08

-2.22 (-6.67%) USD | NASDAQ | Jun 24, 16:00

31.09

+0.01 (+0.03%) After-Hours: 20:00

Cash from Investing (TTM) Chart

Historical Cash from Investing (TTM) Data

View and export this data back to 2015. Upgrade now.

Date	Value
March 31, 2022	-1.424M
December 31, 2021	-1.329M
September 30, 2021	-1.524M
June 30, 2021	-1.005M
March 31, 2021	-1.035M
December 31, 2020	-0.927M
September 30, 2020	-0.792M
June 30, 2020	-0.965M
March 31, 2020	-1.598M
December 31, 2019	-2.673M
September 30, 2019	-2.729M
June 30, 2019	-2.503M
March 31, 2019	-1.688M

Date	Value
December 31, 2018	-0.679M
September 30, 2018	-0.505M
June 30, 2018	-0.554M
March 31, 2018	-0.46M
December 31, 2017	-0.343M
September 30, 2017	-0.266M
June 30, 2017	-0.229M
March 31, 2017	-0.357M
December 31, 2016	-0.339M
September 30, 2016	-0.284M
June 30, 2016	-0.187M
March 31, 2016	-0.268M
December 31, 2015	-0.26M

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Range, Past 5 Years

-2.729M

Minimum

Sep 2019

-0.229M

Maximum

Jun 2017

-1.161M

Average

-0.985M

Median

Cash from Investing (TTM) Benchmarks